The study will focus on Type 2 diabetes patients.
The company, formerly named Thryve, also hired a new CEO and a chief product officer.
This new infusion of cash brings the company's total funding to $28 million.
The company was founded last year and has raised $2.2 million in seed funding.
The companies said their collaboration will improve access to care, particularly for those who would benefit from additional in-person care.
The new technology is being developed for in-hospital and at-home use.
The funding will help clinicians manage elective recovery backlogs in the NHS.
The study found only 46% of patients eligible for prophylactic low-dose aspirin due to high-risk factors for preeclampsia had gotten a provider recommendation by 16 weeks gestation.
Bush discusses his new company Zus and what tech-first providers need right now.
Balanced CEO Katie Reed said general virtual fitness platforms may not take seniors’ needs into account, and options geared toward older adults can be too clinical.
